Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 168 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

 		Plaque, Atherosclerotic Phase4 China NCT06372925

A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy

 		Secondary Malignancies of T-cell Origin Japan NCT07378969

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

 		Cardiovascular Disease and Lipoprotein(a) Phase3 Argentina
Belgium
Brazil
Colombia
Czechia
Germany
India
Israel
Italy
Netherlands
Romania
Slovakia
Spain
Switzerland
Turkey (Türkiye)
United Kingdom
United States
View all
 NCT07517263

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

 		HR+/HER2- Advanced or Metastatic Breast Cancer China NCT07476170

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings

 		Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice Germany NCT07508007

Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China

 		Chronic Myeloid Leukemia in Chronic Phase China NCT07375355

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

 		Immunoglobulin A Nephropathy (IgAN) Phase2 China
Japan
South Korea
Taiwan
United States
View all
 NCT07146906

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

 		Schizophrenia Phase2 United States NCT07467993

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

 		Non-segmental Vitiligo Phase2 Australia
Canada
United States 		NCT07431177

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

 		Huntington Disease Phase3 Canada
United States 		NCT07326709